233 related articles for article (PubMed ID: 14521028)
1. USP publishes enforceable chapter on sterile compounding.
Thompson CA
Am J Health Syst Pharm; 2003 Sep; 60(18):1814, 1817-8, 1822. PubMed ID: 14521028
[No Abstract] [Full Text] [Related]
2. USP general chapter <797> pharmaceutical compounding-sterile preparations.
Hung JC
J Nucl Med; 2004 Jun; 45(6):20N, 28N. PubMed ID: 15181114
[No Abstract] [Full Text] [Related]
3. The potential impact of usp general chapter <797> on procedures and requirements for the preparation of sterile radiopharmaceuticals.
Hung JC
J Nucl Med; 2004 Jun; 45(6):21N-6N. PubMed ID: 15181115
[No Abstract] [Full Text] [Related]
4. Compounding USP <797>: inspection, regulation, and oversight of sterile compounding pharmacies.
Kastango ES
JPEN J Parenter Enteral Nutr; 2012 Mar; 36(2 Suppl):38S-39S. PubMed ID: 22275322
[TBL] [Abstract][Full Text] [Related]
5. Revisions continue on USP sterile-compounding chapter.
Thompson CA
Am J Health Syst Pharm; 2005 Sep; 62(18):1856, 1858, 1861-2. PubMed ID: 16141100
[No Abstract] [Full Text] [Related]
6. Laboratory considerations of United States Pharmacopeia Chapter <71> sterility tests and its application to pharmaceutical compounding.
Hyde TD
Int J Pharm Compd; 2014; 18(1):46-52. PubMed ID: 24881341
[TBL] [Abstract][Full Text] [Related]
7. USP chapter 797: establishing a practice standard for compounding sterile preparations in pharmacy.
Kastango ES; Bradshaw BD
Am J Health Syst Pharm; 2004 Sep; 61(18):1928-38. PubMed ID: 15487884
[No Abstract] [Full Text] [Related]
8. Basics of Sterile Compounding. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 2.
Martin M
Int J Pharm Compd; 2018; 22(6):475-478. PubMed ID: 30384348
[TBL] [Abstract][Full Text] [Related]
9. Does your pharmacy have a compounding isolator?
LaBella CJ
Am J Health Syst Pharm; 2007 Apr; 64(8):855-8. PubMed ID: 17420203
[No Abstract] [Full Text] [Related]
10. Blueprint for implementing USP chapter 797 for compounding sterile preparations.
Kastango ES;
Am J Health Syst Pharm; 2005 Jun; 62(12):1271-88. PubMed ID: 15947127
[TBL] [Abstract][Full Text] [Related]
11. United States Parmacopeia Chapter <797> timeline: 1989 to 2013.
Newton DW
Int J Pharm Compd; 2013; 17(4):283-8. PubMed ID: 24261142
[TBL] [Abstract][Full Text] [Related]
12. The essentials of United States Pharmacopeia Chapter <51> antimicrobial effectiveness testing and its application in pharmaceutical compounding.
Vu N; Nguyen K; Kupiec TC
Int J Pharm Compd; 2014; 18(2):123-30. PubMed ID: 24881116
[TBL] [Abstract][Full Text] [Related]
13. Effect of two work practice changes on the microbial contamination rates of pharmacy-compounded sterile preparations.
Trissel LA; Gentempo JA; Saenz LM; Woodard MY; Angeles CH
Am J Health Syst Pharm; 2007 Apr; 64(8):837-41. PubMed ID: 17420200
[TBL] [Abstract][Full Text] [Related]
14. End-preparation assessments and tests for compounded sterile preparations.
McElhiney LF
Int J Pharm Compd; 2013; 17(4):307-11. PubMed ID: 24261146
[TBL] [Abstract][Full Text] [Related]
15. Quality Assurance and Quality Control: Being Prepared for U.S. Food and Drug Administration Inspections and Staying in Compliance with United States Pharmacopeia Chapter <797>: Part 1.
Martin M
Int J Pharm Compd; 2018; 22(5):401-404. PubMed ID: 30384338
[TBL] [Abstract][Full Text] [Related]
16. Impact of United States Pharmacopeia chapter 797: results of a national survey.
Candy TA; Schneider PJ; Pedersen CA
Am J Health Syst Pharm; 2006 Jul; 63(14):1336-43. PubMed ID: 16809754
[TBL] [Abstract][Full Text] [Related]
17. Adventures in the Environmental World and Environmental Microbiology Sampling of Air for Pharmaceutical Sterile Compounding.
Ligugnana R
Int J Pharm Compd; 2017; 21(3):182-190. PubMed ID: 28557779
[TBL] [Abstract][Full Text] [Related]
18. A needle-free reconstitution and transfer system for compounded sterile intravenous drug solutions in compliance with United States Pharmacopeia Chapter <797> standards.
Marks Z
Int J Pharm Compd; 2014; 18(2):94-9. PubMed ID: 24881111
[TBL] [Abstract][Full Text] [Related]
19. Extemporaneously compounded sterile medications: relevance of new United States pharmacopeial standards to pain clinicians.
Rusho WJ
J Pain Palliat Care Pharmacother; 2004; 18(4):69-76. PubMed ID: 15760810
[TBL] [Abstract][Full Text] [Related]
20. Joint Commission expectations related to USP-NF Chapter 797 on compounding sterile preparations.
Jt Comm Perspect; 2006 Apr; 26(4):5. PubMed ID: 16786622
[No Abstract] [Full Text] [Related]
[Next] [New Search]
